In fact, the quantification of protein levels in fibroblasts and lymphoblastoid cell lines demonstrated that CMT2S patients have significantly higher IGHMBP2 protein levels than SMARD1 patients, although a defective truncated protein was found in many cases. The gene discussed is IGHMBP2; the disease is Spinal muscular atrophy with respiratory distress type 1.